Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-17 Sale |
2022-02-22 4:19 pm |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
1,306 | $12.12 | $15,833 | 129,450 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:27 pm |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
1,704 | $9.862 | $16,805 | 130,756 (Direct) |
View |
| 2021-05-07 Purchase |
2021-05-11 08:58 am |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
23,250 | $8.6018 | $199,992 | 131,802 (Direct) |
View |
| 2021-02-18 Sale |
2021-02-22 8:12 pm |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
1,186 | $14.83 | $17,590 | 51,791 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-17 6:48 pm |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
1,748 | $15.52 | $27,127 | 62,677 (Direct) |
View |
| 2020-07-15 Sale |
2020-11-04 8:16 pm |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
589 | $19.46 | $11,462 | 50,466 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-07-12 Tax Withholding |
2021-07-13 6:21 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
665 | $9.73 | 131,137 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:17 pm |
N/A 2031-02-24 |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
81,981 | $0 | 167,659 (Direct) |
View |
| 2021-02-15 Exercise |
2021-02-17 6:48 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
4,850 | $0 | 62,677 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 9:56 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
5,650 | $0 | 66,825 (Direct) |
View |
| 2020-07-11 Exercise |
2020-11-04 8:16 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
2,413 | $0 | 50,466 (Direct) |
View |